Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 58,809	$ 55,499
Marketable securities, current	133,075	189,405
Accounts receivable	6,542	3,102
Prepaid expenses and other current assets	8,438	9,761
Total current assets	206,864	257,767
Marketable securities, non-current	7,875	22,359
Property and equipment, net	5,134	5,842
Right-of-use asset	41,961	57,536
Restricted cash	3,443	3,443
Other assets	211	2,655
Total assets	265,488	349,602
Current liabilities:
Accounts payable	1,333	1,328
Accrued expenses and other current liabilities	11,270	19,363
Deferred revenue, current	17,126	18,712
Operating lease liability, current	6,216	5,774
Total current liabilities	35,945	45,177
Deferred revenue, net of current	19,888	28,457
Operating lease liability, net of current	55,247	59,982
Total liabilities	111,080	133,616
Commitments and contingencies (see Note 11)
Stockholders’ equity:
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of September 30, 2025 and December 31, 2024, respectively	0	0
Common stock, par value of $0.0001 per share; 300,000,000 and 150,000,000 shares authorized as of September 30, 2025, and December 31, 2024, respectively, and 74,174,515 and 70,625,899 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	7	7
Additional paid-in capital	872,521	849,625
Accumulated other comprehensive income	87	53
Accumulated deficit	(718,207)	(633,699)
Total stockholders’ equity	154,408	215,986
Total liabilities and stockholders’ equity	$ 265,488	$ 349,602
Common stock, shares authorized (in shares)	300,000,000	150,000,000